ImmuneTarget, Inc

ImmuneTarget is a biopharmaceutical company focusing on the development of novel therapies to treat cancers and autoimmune diseases. Our research platform bases on critical modules of immune cell functions and validated by genetic evidences.

Focus area
Oncology
Commencement date
06/10/2015